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Resveratrol and sulphoraphane have been shown to act by means 
of the PI3K signaling pathway. Treatment response to resveratrol is 
shown in Fig. E and F using hyperpolarization and RP-HPLC 
measurements respectively.  
 
Glutamine metabolism is decreased after drug treatment as 
determined by both assays. 
 
Hyperpolarized [5-13C]glutamine metabolism thus is a promising 
biomarker for the non-invasive detection of tumor response to 
treatment, as it directly monitors one of the hallmarks in cancer 
metabolism - glutaminolysis - in living cells3.  
Non-invasive study of metabolism 
A trick called “hyperpolarization” allows real-time NMR 
detection of reaction cascades in living cells. Systems function 
and responses to genetic, nutritional or toxic intervention can 
be directly visualized by fast and easy-to interpret in vivo 
assays. 
 
Hyperpolarized magnetic resonance spectroscopy (Hyperpolarized 
MRS) of 13C-labeled compounds can be used to to estimate rates for 
specific enzymatic reactions in vitro and in vivo. Furthermore, for 
some hyperpolarized 13C-labeled substrates there is sufficient signal 
for the spatial distribution of both the substrate and its metabolites to 
be imaged in vivo. 
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Glutaminolytic phenotypes 
Fig. A Real time glutamine metabolism in DU145 a human prostate 
cancer cell line using [5-13C]glutamine. B) Single spectrum after 20 s 
from the dynamic series shown in A).  
  
The real time conversion of glutamine to glutamate is easily followed. 
It was evaluated, if hyperpolarized [5-13C]glutamine metabolism is a 
possible biomarker for the glutamine dependence in prostate cancer 
cells. 
 
Area under the curves of hyperpolarized [5-13C]glutamate is found to 
be 4 times higher in the  by using hyperpolarized [5-13C]glutamine as 
a non-invasive probe (Fig. C). Invasive RP-HPLC assay determining 
the glutaminase activity shows similar result (Fig D). 
Metabolic response to drug treatment 
Resveratrol and sulforaphane are two examples of natural 
compounds that have attracted attention for their selective 
toxicity to cancer cells and their ability to sensitize cancer cells 
to other therapies1,2.  
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For some cancer cells, activation of the PI3K signaling pathway 
is instrumental in causing increased levels of glucose. In other 
cancer cells, the same signaling pathway leads to an inefficient 
glutamine metabolism rather than excess glucose metabolism. 
DU145 cells are more glutaminolytic than the PC3 cells. This is 
shown by the MTT assay under growth conditions with and without 
glutamine (Fig. C and D).  
Metabolic response to glutaminolysis 
The proliferative dependency on glutamine availability 
supposedly correlates to activated oncogenes that influence 
glutamine catabolism.  
E F 
G H 
C D 
A B 
